C86.30 — Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
C86.30 is a billable, specific ICD-10-CM code for subcutaneous panniculitis-like t-cell lymphoma not having achieved remission. It is valid for submission on a claim.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Subcutaneous panniculitis-like T-cell lymphoma NOS
- Subcutaneous panniculitis-like T-cell lymphoma with failed remission
Other codes that can never be billed with C86.30
These codes carry an Excludes1 note pointing at C86.30. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading C86.30 alone.
- C84.ZOther mature T/NK-cell lymphomas
Risk adjustment
C86.30 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 19 Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers1.798 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C86.30 is named in 40 Medicare coverage policies — 40 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C86.3. If C86.30 is not quite right, the correct code is usually one of these.
Questions about C86.30
- Is C86.30 a billable ICD-10-CM code?
- Yes. C86.30 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C86.30 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).